CA-16450/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1980	1
1981	3
1982	3
1983	1
1985	2
1987	3
1988	2
1989	1
1990	4
1992	2
1993	1
1995	1
1997	1
2001	1
2002	1
2004	2
2006	1
2007	1
2008	1
2024	0

1

Laboratory and clinical studies of biochemical modulation by hydroxyurea.

Schilsky RL, Ratain MJ, Vokes EE, Vogelzang NJ, Anderson J, Peterson BA. Schilsky RL, et al. Semin Oncol. 1992 Jun;19(3 Suppl 9):84-9. Semin Oncol. 1992. PMID: 1641659 Review.

2

5-Azacytidine and renal tubular dysfunction.

Peterson BA, Collins AJ, Vogelzang NJ, Bloomfield CD. Peterson BA, et al. Blood. 1981 Jan;57(1):182-5. Blood. 1981. PMID: 6160887 Free article.

3

Mitoxantrone and constant infusion etoposide for relapsed and refractory acute myelocytic leukemia.

Paciucci PA, Davis RB, Holland JF, Martelo O, Schiffer CA. Paciucci PA, et al. Am J Clin Oncol. 1990 Dec;13(6):516-9. doi: 10.1097/00000421-199012000-00013. Am J Clin Oncol. 1990. PMID: 2239806 Clinical Trial.

4

Rosette formation in malignant lymphoma.

Frizzera G, Gajl-Peczalska K, Sibley RK, Rosai J, Cherwitz D, Hurd DD. Frizzera G, et al. Am J Pathol. 1985 Jun;119(3):351-6. Am J Pathol. 1985. PMID: 2409804 Free PMC article.

5

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.

Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF 3rd, Green MR. Dillman RO, et al. N Engl J Med. 1990 Oct 4;323(14):940-5. doi: 10.1056/NEJM199010043231403. N Engl J Med. 1990. PMID: 2169587 Free article. Clinical Trial.

6

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

Spiegelman D, Maurer LH, Ware JH, Perry MC, Chahinian AP, Comis R, Eaton W, Zimmer B, Green M. Spiegelman D, et al. J Clin Oncol. 1989 Mar;7(3):344-54. doi: 10.1200/JCO.1989.7.3.344. J Clin Oncol. 1989. PMID: 2537384

7

Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832).

Luikart SD, Herndon JE 2nd, Hollis DR, MacDonald M, Maurer LH, Crawford J, Clamon GH, Wright J, Perry MC, Ozer H, Green MR. Luikart SD, et al. Am J Clin Oncol. 1997 Feb;20(1):24-30. doi: 10.1097/00000421-199702000-00006. Am J Clin Oncol. 1997. PMID: 9020283 Clinical Trial.

8

Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trial.

Chiuten DF, Vosika GJ, Shaw MT, Boiron M, Gisselbrecht C, Marty M, Higgins G, Muggia FM. Chiuten DF, et al. Anticancer Res. 1981;1(2):121-4. Anticancer Res. 1981. PMID: 7347155

9

Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma.

Ozer H, Anderson JR, Peterson BA, Budman DR, Henderson ES, Bloomfield CD, Gottlieb A. Ozer H, et al. Invest New Drugs. 1987;5 Suppl:S27-33. doi: 10.1007/BF00207260. Invest New Drugs. 1987. PMID: 3298131 Clinical Trial.

10

Effect of age on therapeutic response and survival in advanced Hodgkin's disease.

Peterson BA, Pajak TF, Cooper MR, Nissen NI, Glidewell OJ, Holland JF, Bloomfield CD, Gottlieb AJ. Peterson BA, et al. Cancer Treat Rep. 1982 Apr;66(4):889-98. Cancer Treat Rep. 1982. PMID: 7042088 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year